Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.

Wierda, WG; Rawstron, A; Cymbalista, F; Badoux, X; Rossi, D; Brown, JR; Egle, A; Abello, V; Ceballos, EC; Herishanu, Y; Mulligan, SP; Niemann, CU; Diong, CP; Soysal, T; Suzuki, R; Tran, HTT; Wu, SJ; Owen, C; Stilgenbauer, S; Ghia, P; Hillmen, P LEUKEMIA. 2021; 35(11): 3059-3072.

The interrelationship of smoking, CD4+ cell count, viral load and cancer in persons living with HIV.

The RESPOND study group AIDS. 2021; 35(5): 747-757.

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R BREAST CANCER RES. 2021; 23(1): 112

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature.

Schlick, K; Kiem, D; Greil, R; Biomolecules. 2021; 11(10):

Cytotoxic Compounds of Two Demosponges (Aplysina aerophoba and Spongia sp.) from the Aegean Sea

Orfanoudaki, M; Hartmann, A; Alilou, M; Mehic, N; Kwiatkowski, M; Johrer, K; Ngoc, HN; Hensel, A; Greil, R; Ganzera, M BIOMOLECULES. 2021; 11(5): 723

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

Fitzal, F; Filipits, M; Fesl, C; Rudas, M; Greil, R; Balic, M; Moinfar, F; Herz, W; Dubsky, P; Bartsch, R; Ferree, S; Schaper, C; Gnant, M BRIT J SURG. 2021; 108(3): 308-314.

Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

Schlintl, V; Huemer, F; Greil, R; Weiss, L; J Gastrointest Oncol. 2021; 12(2): 906-909.

Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)

Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R BREAST CARE. 2021;

Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae)

Cicek, SS; Willer, J; Preziuso, F; Sonnichsen, F; Greil, R; Girreser, U; Zidorn, C; Johrer, K RSC ADV. 2021; 11(18): 10489-10496.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M BRIT J CANCER. 2021;